208 related articles for article (PubMed ID: 32350589)
1. Comparative mitochondrial proteomics of Leishmania tropica clinical isolates resistant and sensitive to meglumine antimoniate.
Tasbihi M; Shekari F; Hajjaran H; Khanmohammadi M; Hadighi R
Parasitol Res; 2020 Jun; 119(6):1857-1871. PubMed ID: 32350589
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
Hajjaran H; Azarian B; Mohebali M; Hadighi R; Assareh A; Vaziri B
East Mediterr Health J; 2012 Feb; 18(2):165-71. PubMed ID: 22571094
[TBL] [Abstract][Full Text] [Related]
3. [Determination of Antimony Resistance Mechanism of Leishmania tropica Causing Cutaneous Leishmaniasis in Turkey].
Özbilgin A; Zeyrek FY; Güray MZ; Çulha G; Akyar I; Harman M; Özbel Y; Ertabaklar H; Çavuş İ; Gündüz C
Mikrobiyol Bul; 2020 Jul; 54(3):444-462. PubMed ID: 32755520
[TBL] [Abstract][Full Text] [Related]
4. Comparison of
Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
[TBL] [Abstract][Full Text] [Related]
5. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
Oliaee RT; Sharifi I; Afgar A; Kareshk AT; Asadi A; Heshmatkhah A; Bamorovat M; Jafarzadeh A; Mohammadi MA; Daneshvar H
Trop Med Int Health; 2018 Jun; 23(6):622-633. PubMed ID: 29709098
[TBL] [Abstract][Full Text] [Related]
6. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial proteome profiling of Leishmania tropica.
Tasbihi M; Shekari F; Hajjaran H; Masoori L; Hadighi R
Microb Pathog; 2019 Aug; 133():103542. PubMed ID: 31125686
[TBL] [Abstract][Full Text] [Related]
8. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
Nateghi-Rostami M; Tasbihi M; Darzi F
Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
[TBL] [Abstract][Full Text] [Related]
9. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
Hajjaran H; Kazemi-Rad E; Mohebali M; Oshaghi MA; Khadem-Erfan MB; Hajaliloo E; Reisi Nafchi H; Raoofian R
Int J Dermatol; 2016 Sep; 55(9):1020-6. PubMed ID: 27336481
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
Özbilgin A; Çavuş İ; Yıldırım A; Kaya T; Ertabaklar H
Turkiye Parazitol Derg; 2018 Mar; 42(1):11-19. PubMed ID: 29780014
[TBL] [Abstract][Full Text] [Related]
12. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
[TBL] [Abstract][Full Text] [Related]
13. Insights into the trypanothione system in antimony-resistant and sensitive Leishmania tropica clinical isolates.
Valashani HT; Ahmadpour M; Naddaf SR; Mohebali M; Hajjaran H; Latifi A; Salimi M; Farahmand M; Naeimi S; Raissi V; Kazemirad E
Acta Trop; 2024 Jun; 254():107190. PubMed ID: 38508372
[TBL] [Abstract][Full Text] [Related]
14. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.
Mohebali M; Kazemirad E; Hajjaran H; Kazemirad E; Oshaghi MA; Raoofian R; Teimouri A
Arch Dermatol Res; 2019 Jan; 311(1):9-17. PubMed ID: 30390113
[TBL] [Abstract][Full Text] [Related]
16. Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp.
Fernández O; Diaz-Toro Y; Valderrama L; Ovalle C; Valderrama M; Castillo H; Perez M; Saravia NG
J Clin Microbiol; 2012 Jul; 50(7):2207-11. PubMed ID: 22518860
[TBL] [Abstract][Full Text] [Related]
17. Resistance of
Regli IB; Fernández OL; Martínez-Salazar B; Gómez MA; Saravia NG; Tacchini-Cottier F
Front Immunol; 2018; 9():3040. PubMed ID: 30622537
[No Abstract] [Full Text] [Related]
18. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
Shokri A; Sharifi I; Khamesipour A; Nakhaee N; Fasihi Harandi M; Nosratabadi J; Hakimi Parizi M; Barati M
Parasitol Res; 2012 Mar; 110(3):1113-7. PubMed ID: 21847598
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
Carrió J; Portús M
BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.
Jeddi F; Mary C; Aoun K; Harrat Z; Bouratbine A; Faraut F; Benikhlef R; Pomares C; Pratlong F; Marty P; Piarroux R
Antimicrob Agents Chemother; 2014 Aug; 58(8):4866-74. PubMed ID: 24913173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
